Fate Therapeutics paid its 3 named executives $4.1M in total in FY2025 (Dec). CEO Bahram Valamehr, Ph.D. was paid $2.2M of that.
Pay$100 in the stock at the end of FY21 → $2
Pay of each named executive
Bahram Valamehr, Ph.D.President, Chief Executive Officer and Director
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Cindy R. Tahl, J.D.Chief Legal & Compliance Officer and Corporate Secretary
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Kamal Adawi, M.S., MBAChief Financial Officer and Treasurer
| FY2025 (Dec) |
1 year
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.